利索-全球专利检索

  1. Login
  2. Sign Up

Search Results

92 records (took 0.015 seconds)

    SYNERGISTIC CANCER THERAPY DRUG COMBINATIONS
    5.
    发明申请
    SYNERGISTIC CANCER THERAPY DRUG COMBINATIONS 审中-公开
    协同治疗药物联合治疗

    公开(公告)号：WO2015077250A8

    公开(公告)日：2015-06-18

    申请号：PCT/US2014066221

    申请日：2014-11-18

    Applicant: LIFE PLUS LLC

    Inventor： ZAID GENE H ,  BURGOYNE THOMAS W ,  STEHNO-BITTEL LISA ,  LEE-STANISLAV MARY ANN

    IPC: A61K36/00

    CPC classification number: A61K36/888 ,  A61K31/11 ,  A61K31/192 ,  A61K31/196 ,  A61K31/202 ,  A61K31/337 ,  A61K31/439 ,  A61K31/475 ,  A61K31/513 ,  A61K31/519 ,  A61K31/53 ,  A61K31/575 ,  A61K31/704 ,  A61K31/7068 ,  A61K33/24 ,  A61K38/164 ,  A61K45/06 ,  A61K2300/00

    Abstract: Synergistic cancer therapy drug combinations include therapeutically effective amounts of at least one chemotherapeutic drug or agent with a fortified decoction dosage form comprising from about 10 mg to about 6,000 mg each of β-sitosterol, isovanillin, and linolenic acid. The decoction dosage preferably includes plant extract(s) of the genus Arum fortified with effective amounts of β-sitosterol, isovanillin, and linolenic acid not derived from the plant. The combination may be in various forms including aqueous dispersions, gels, ampules, powders, capsules, pills, or tablets, and are normally administered orally to patients. The anticancer combinations have therapeutic effects on cancerous tissue which are greater than the sum of the individual therapeutic effects of the fortified decoction dosage form and the at least one chemotherapeutic agent on the cancerous tissue.

    Abstract translation: 协同治疗药物组合包括治疗有效量的至少一种具有强化煎剂剂型的化疗药物或药剂，其包含约10mg至约6,000mg的β-谷甾醇，异喹啉腈和亚麻酸。 煎剂剂量优选包括用有效量的β-谷甾醇，异喹啉腈和非植物来源的亚麻酸加强的Arum属植物提取物。 该组合可以是各种形式，包括水性分散体，凝胶，安瓿，粉末，胶囊，丸剂或片剂，并且通常口服给患者。 抗癌组合对癌组织具有治疗效果，其大于癌组织上强化煎剂剂型和至少一种化学治疗剂的单独治疗作用的总和。

    SYNERGISTIC CANCER THERAPY DRUG COMBINATIONS
    6.
    发明申请
    SYNERGISTIC CANCER THERAPY DRUG COMBINATIONS 审中-公开
    协同性癌症治疗药物组合

    公开(公告)号：WO2015077250A1

    公开(公告)日：2015-05-28

    申请号：PCT/US2014/066221

    申请日：2014-11-18

    Applicant: LIFE PLUS, LLC

    Inventor： ZAID, Gene H. ,  BURGOYNE, Thomas W. ,  STEHNO-BITTEL, Lisa ,  LEE-STANISLAV, Mary Ann

    IPC: A61K36/00

    CPC classification number: A61K36/888 ,  A61K31/11 ,  A61K31/192 ,  A61K31/196 ,  A61K31/202 ,  A61K31/337 ,  A61K31/439 ,  A61K31/475 ,  A61K31/513 ,  A61K31/519 ,  A61K31/53 ,  A61K31/575 ,  A61K31/704 ,  A61K31/7068 ,  A61K33/24 ,  A61K38/164 ,  A61K45/06 ,  A61K2300/00

    Abstract: Synergistic cancer therapy drug combinations include therapeutically effective amounts of at least one chemotherapeutic drug or agent with a fortified decoction dosage form comprising from about 10 mg to about 6,000 mg each of β-sitosterol, isovanillin, and linolenic acid. The decoction dosage preferably includes plant extract(s) of the genus Arum fortified with effective amounts of β-sitosterol, isovanillin, and linolenic acid not derived from the plant. The combination may be in various forms including aqueous dispersions, gels, ampules, powders, capsules, pills, or tablets, and are normally administered orally to patients. The anticancer combinations have therapeutic effects on cancerous tissue which are greater than the sum of the individual therapeutic effects of the fortified decoction dosage form and the at least one chemotherapeutic agent on the cancerous tissue.

    Abstract translation: 协同癌症治疗药物组合包括治疗有效量的至少一种化疗药物或具有强化的水煎剂型的药剂，其包含约10mg至约6,000mg的β-谷甾醇，异香草醛和亚麻酸 酸。 煎煮剂量优选包括强化有效量的β-谷甾醇，异香草醛和不来自植物的亚麻酸的阿鲁姆属植物提取物。 该组合可以是各种形式，包括水分散液，凝胶，安瓿，粉末，胶囊，丸剂或片剂，并且通常口服给予患者。 抗癌组合对癌组织具有治疗效果，其大于强化的煎剂剂型和至少一种化疗剂对癌组织的个体治疗效果的总和。

    NATURAL PLANT PRODUCTS FOR CONTROL OF CANCER METASTASIS
    8.
    发明申请
    NATURAL PLANT PRODUCTS FOR CONTROL OF CANCER METASTASIS 审中-公开
    用于控制癌症转移的天然植物产品

    公开(公告)号：WO2011115651A2

    公开(公告)日：2011-09-22

    申请号：PCT/US2010/061073

    申请日：2010-12-17

    Applicant: UNIVERSITY OF MARYLAND, BALTIMORE ,  FULTON, Amy ,  KUNDU, Namita

    Inventor： FULTON, Amy ,  KUNDU, Namita

    IPC: A61K38/56 ,  A61K38/16 ,  A61K36/888 ,  A61P35/00

    CPC classification number: A61K36/888 ,  A61K38/168 ,  A61K38/56

    Abstract: The invention provides compositions comprising soluble extracts or isolated polypeptides from the edible roots of the plant Colocasia, such as Coiocasia esculenta, commonly known as Taro, and from Xantkosoma, such as Xanthosoma sagittifolium, commonly known as Malanga Blanca or Yautia. The compositions exhibit inhibitory effects on metastasis of cancer cells in particular breast and prostate cancer cells and have therapeutic pharmacological activity, Pharmaceutical compositions for the treatment of cancer by inhibiting metastasis which comprises an effective amount of the described extract or isolated polypeptide thereof and optionally a pharmaceutical acceptable carrier are described.

    Abstract translation: 本发明提供了包含可溶性提取物或分离多肽的组合物，所述可溶性提取物或分离多肽来自植物芋（Carocasia）的可食用根，例如通常称为Taro的Coiocasia esculenta和来自Xantkosoma的Xanthosoma sagittifolium，通常称为Malanga 布兰卡或Yautia。 所述组合物对癌细胞特别是乳腺癌和前列腺癌细胞的转移具有抑制作用，并具有治疗药理学活性。用于通过抑制转移来治疗癌症的药物组合物，其包含有效量的所述提取物或其分离的多肽和任选的药物 描述了可接受的载体。

    ARZNEIMITTEL
    10.
    发明申请
    ARZNEIMITTEL 审中-公开
    药物

    公开(公告)号：WO2005099727A1

    公开(公告)日：2005-10-27

    申请号：PCT/DE2004/001100

    申请日：2004-05-25

    Applicant: GREIFENSTEIN, Peter

    Inventor： GREIFENSTEIN, Peter

    IPC: A61K35/78

    CPC classification number: A61K36/06 ,  A61K36/185 ,  A61K36/73 ,  A61K36/736 ,  A61K36/87 ,  A61K36/88 ,  A61K36/888 ,  A61K36/899 ,  A61K36/8998 ,  A61K2300/00

    Abstract: Die vorliegende Erfindung offenbart ein Arzneimittel mit einem Gehalt an Bestandteilen und/oder an Extrakten von Prunus armenica und von Cocos nucifera und von Humulus lupulus und von gekeimter Gerste oder gekeimtem Roggen oder gekeimtem Weizen und von Myceten und von aus dem Traubensaft der Weinrebe durch alkoholische Gärung gewonnener Flüssigkeit und von Musazeen und von Blättern von Rubus, jeweils als Wirkstoff, welches zur Behandlung von AIDS, Krebs oder Erkrankungen der Psyche oder von Nervenkrankheiten einsetzbar ist.

    Abstract translation: 本发明公开了一种具有的成分和/或樱桃armenica和的和啤酒花的椰子的提取物的含量的药物组合物和发芽的大麦或发芽黑麦或发芽小麦和霉菌的进出通过酒精发酵葡萄树的葡萄汁 并从分别Musazeen和悬钩子的叶，将得到的液体作为活性成分，其可用于艾滋病，癌症或心理的或神经性疾病的疾病的治疗。

Patent Agency Ranking